We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Midatech Pharma Plc | LSE:MTPH | London | Ordinary Share | GB00BNGF1L75 | ORD GBP0.02 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 18.00 | 17.00 | 19.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
TIDMMTPH TIDM84JL
RNS Number : 5216U
Midatech Pharma PLC
29 July 2020
TR-1: S tandard form for notification of major holdings
Hot Features
Premium
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible) (i)
1a. Identity of the issuer or the MIDATECH PHARMA PLC
underlying issuer of existing shares
to which voting rights are attached
(ii) :
-----------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
Non-UK issuer
----
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights X
----
An acquisition or disposal of financial instruments
----
An event changing the breakdown of voting rights
----
Other (please specify)(iii) :
----
3. Details of person subject to the notification obligation (iv)
Name Bank of America Corporation
City and country of registered office Wilmington, DE, United States
(if applicable)
4. Full name of shareholder(s) (if different from 3.) (v)
Name BofA Securities, Inc.
-----------------------------------------------
City and country of registered office Wilmington, DE, United States
(if applicable)
-----------------------------------------------
5. Date on which the threshold was 27(th) July 2020
crossed or reached (vi) :
-----------------------------------------------
6. Date on which issuer notified (DD/MM/YYYY): 29(th) July 2020
-----------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting rights
to shares (total instruments 8.B) of issuer (vii)
of 8. A) (total of 8.B
1 + 8.B 2)
------------------ --------------------- ----------------- --------------------
Resulting situation
on the date
on which threshold
was crossed
or reached 4.402% 0 % 4.402% 39,252,557
------------------ --------------------- ----------------- --------------------
Position of Below Notifiable Below Notifiable Below Notifiable
previous notification Threshold Threshold Threshold
(if
applicable)
------------------ --------------------- ----------------- --------------------
8. Notified details of the resulting situation on the date on which
the threshold was crossed or reached (viii)
A: Voting rights attached to shares
Class/type of Number of voting rights % of voting rights
shares (ix)
ISIN code (if
possible)
Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of
2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) Directive
(DTR5.1) (DTR5.2.1) 2004/109/EC)
(DTR5.2.1)
-----------------------------
US59564R3021 1,728,050 4.402%
---------------------- ----------------------------- ------------------------- ---------------
SUBTOTAL 8. A 1,728,050 4.402%
----------------------------------------------------- ------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC
(DTR5.3.1.1 (a))
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date (x) Conversion rights that may be rights
Period (xi) acquired if the instrument
is
exercised/converted.
---------------------- --------------------- --------------------------------- ---------------
N/A N/A N/A N/A N/A
---------------------- --------------------- --------------------------------- ---------------
SUBTOTAL 8. N/A N/A
B 1
--------------------- --------------------------------- ---------------
B 2: Financial Instruments with similar economic effect according to
Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of Expiration Exercise/ Physical or Number of % of voting
financial date (x) Conversion cash voting rights rights
instrument Period (xi) settlement
(xii)
------------------ -------------------- ---------------------- --------------------
N/A N/A N/A N/A N/A N/A
------------------ -------------------- ---------------------- --------------------
SUBTOTAL 8.B.2 N/A N/A
---------------------- --------------------
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled
by any natural person or legal entity and does not control any other
undertaking(s) holding directly or indirectly an interest in the
(underlying) issuer (xiii)
Full chain of controlled undertakings through which the voting rights X
and/or the
financial instruments are effectively held starting with the ultimate
controlling natural person or legal entity (xiv) (please add additional
rows as necessary)
Name (xv) % of voting % of voting rights Total of both
rights if it through financial if it equals
equals or is instruments if or is higher
higher than it equals or is than the notifiable
the notifiable higher than the threshold
threshold notifiable threshold
Bank of America N/A N/A N/A
Corporation
---------------- ---------------------- ---------------------
NB Holdings N/A N/A N/A
Corporation
---------------- ---------------------- ---------------------
BofA Securities, Inc. 4.402% N/A 4.402%
---------------- ---------------------- ---------------------
Bank of America N/A N/A N/A
Corporation
---------------- ---------------------- ---------------------
NB Holdings N/A N/A N/A
Corporation
---------------- ---------------------- ---------------------
BAC North America N/A N/A N/A
Holding
Company
---------------- ---------------------- ---------------------
Bank of America, N/A N/A N/A
National
Association
---------------- ---------------------- ---------------------
-----------------------------------------------------------------------------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder
--------------------------------------
The number and % of voting rights held
--------------------------------------
The date until which the voting rights
will be held
--------------------------------------
11. Additional information (xvi)
Place of completion United Kingdom
Date of completion 29(th) July 2020
-----------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
HOLRLMATMTJTBJM
(END) Dow Jones Newswires
July 29, 2020 11:35 ET (15:35 GMT)
1 Year Midatech Pharma Chart |
1 Month Midatech Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
